Find the standard you are looking for at Engineering360. Documents are available for purchase from the IHS Standards Store.

1 - 16 of 16 results

WILEY - PLASTIC PACKAGING: INTERA - PLASTIC PACKAGING: INTERACTIONS WITH FOOD AND PHARMACEUTICALS 2ND COMPLETELY REVISED EDITION COMPLETE DOCUMENT Organization: WILEY
Date: 2008-01-01
Description: This successful book, now in its second edition, covers all the important aspects of plastic packaging materials and the interdisciplinary knowledge needed by food chemists, pharmaceutical chemists, food technologists, materials scientists, process engineers, and product developers alike.
HHS - 21 CFR PART 1141 - CIGARETTE PACKAGE AND ADVERTISING WARNINGS Organization: HHS
Date: 2014-04-01
Description: (a) This part sets forth the requirements for the display of health warnings on cigarette packages and in advertisements for cigarettes. FDA may require additional statements to be displayed on packages and in advertisements under the Federal Food, Drug, and Cosmetic Act or other authorities.
HHS - 21 CFR PART 1141 - CIGARETTE PACKAGE AND ADVERTISING WARNINGS Organization: HHS
Date: 2015-04-01
Description: (a) This part sets forth the requirements for the display of health warnings on cigarette packages and in advertisements for cigarettes. FDA may require additional statements to be displayed on packages and in advertisements under the Federal Food, Drug, and Cosmetic Act or other authorities.
HHS - 21 CFR PART 1141 - CIGARETTE PACKAGE AND ADVERTISING WARNINGS Organization: HHS
Date: 2017-04-01
Description: (a) This part sets forth the requirements for the display of health warnings on cigarette packages and in advertisements for cigarettes. FDA may require additional statements to be displayed on packages and in advertisements under the Federal Food, Drug, and Cosmetic Act or other authorities.
HHS - 21 CFR PART 1141 - CIGARETTE PACKAGE AND ADVERTISING WARNINGS Organization: HHS
Date: 2016-04-01
Description: (a) This part sets forth the requirements for the display of health warnings on cigarette packages and in advertisements for cigarettes. FDA may require additional statements to be displayed on packages and in advertisements under the Federal Food, Drug, and Cosmetic Act or other authorities.
CRC - E68628 - READY-TO-EAT FOODS : MICROBIAL CONCERNS AND CONTROL MEASURES Organization: CRC
Date: 2010-03-03
Description: Several severe and high-profile outbreaks of food-borne illness linked to the consumption of RTE foods have prompted the USDA and FDA to issue stringent rules and regulations governing the manufacturing of RTE foods.
HHS - 21 CFR PART 830 - UNIQUE DEVICE IDENTIFICATION Organization: HHS
Date: 2014-04-01
Description: FDA, we, or us means the Food and Drug Administration. Federal Food, Drug, and Cosmetic Act means 21 U.S.C. 321 et seq., as amended.
HHS - 21 CFR PART 830 - UNIQUE DEVICE IDENTIFICATION Organization: HHS
Date: 2017-04-01
Description: Expiration date means the date by which the label of a device states the device must or should be used. FDA, we, or us means the Food and Drug Administration.
CRC - HE7741 - DIETARY SUPPLEMENT GOOD MANUFACTURING PRACTICES : PREPARING FOR COMPLIANCE Organization: CRC
Date: 2016-04-19
Description: Dietary Supplement GMP is a one-stop "how-to" road map to the final dietary supplement GMP regulations recently issued by the FDA covering the manufacture, packaging, and holding of dietary supplement products.
AAMI ST91 - FLEXIBLE AND SEMI-RIGID ENDOSCOPE PROCESSING IN HEALTH CARE FACILITIES Organization: AAMI
Date: 2015-01-01
Description: d) The processing of devices labeled for single use only (see Food and Drug Administration [FDA], 2000c). NOTEā€”For more information on the subjects excluded from the scope of this recommended practice, and for additional background information on the inclusions, refer to the references listed in the bibliography.
AAMI ST58 - CHEMICAL STERILIZATION AND HIGH-LEVEL DISINFECTION IN HEALTH CARE FACILITIES Organization: AAMI
Date: 2013-01-01
Description: General This recommended practice provides guidelines for the selection and use of liquid chemical sterilants (LCSs)/highlevel disinfectants (HLDs) and gaseous chemical sterilizers that have been cleared for marketing by the U.S. Food and Drug Administration (FDA) for use in hospitals and other health care facilities.
HHS - 21 CFR PART 820 - QUALITY SYSTEM REGULATION Organization: HHS
Date: 2014-04-01
Description: If a manufacturer who offers devices for import into the United States refuses to permit or allow the completion of a Food and Drug Administration (FDA) inspection of the foreign facility for the purpose of determining compliance with this part, it shall appear for purposes of section 801(a) of the act, that the methods used in, and the facilities and controls used for, the design, manufacture, packaging, labeling, storage, installation, or servicing of any devices produced at such facility that are offered for import into the United States do not conform to the requirements of section 520(f) of the act and this part and that the devices manufactured at that facility are adulterated under section 501(h) of the act.
HHS - 21 CFR PART 820 - QUALITY SYSTEM REGULATION Organization: HHS
Date: 2017-04-01
Description: If a manufacturer who offers devices for import into the United States refuses to permit or allow the completion of a Food and Drug Administration (FDA) inspection of the foreign facility for the purpose of determining compliance with this part, it shall appear for purposes of section 801(a) of the act, that the methods used in, and the facilities and controls used for, the design, manufacture, packaging, labeling, storage, installation, or servicing of any devices produced at such facility that are offered for import into the United States do not conform to the requirements of section 520(f) of the act and this part and that the devices manufactured at that facility are adulterated under section 501(h) of the act.
CLSI POCT17 - USE OF GLUCOSE METERS FOR CRITICALLY ILL PATIENTS - VOL 36; NO 4 Organization: CLSI
Date: 2016-03-01
Description: Alternatively, organizations should be advised to review their management plan with the Centers for Medicare & Medicaid Services and US Food and Drug Administration (FDA) representatives, if necessary.
API - PUBL 4560 - A 90-DAY FEEDING STUDY IN THE RAT WITH SIX DIFFERENT WHITE MINERAL OILS (N15 (H), N70 (H), N70 (A), P15 (H), N10 (A), AND P100 (H), THREE DIFFERENT MINERAL WAXES (A LOW MELTING POINT WAX, A HIGH MELTING POINT WAX AND A HIGH SULPHUR WAX) AND COCONUT OIL Organization: API
Date: 1992-01-01
Description: Background Historically, white oils and waxes have an established use in applications related to food processing and packaging. For a large number of years, these materials were produced by acid (oleum) treatment of solvent-extracted refinery streams to yield products of the required physical and technical specification.
HHS - 21 CFR UCM 259748 - APPLYING HUMAN FACTORS AND USABILITY ENGINEERING TO MEDICAL DEVICES Organization: HHS
Date: 2016-02-03
Description: ., maximizing ease of use, efficiency, and user satisfaction), FDA is primarily concerned that devices are safe and effective for the intended users, uses, and use environments.

1 - 16 of 16 results